Stay updated with the latest type-2-diabetes news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on type-2-diabetes topics.
Ahmedabad: Zydus Lifesciences has expanded its presence in the U.S. generics market with a key regulatory approval for a widely used diabetes treatment. Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Dapagliflozin Tablets in 5 mg and 10 mg strengths. This approval enables the company to enter the U.S. market with a generic version of the drug, broadening its portfolio in a high-demand therapeutic category. With the approval, Zydus ...Read More >
Bengaluru: Biocon Limited has achieved a regulatory milestone in the United States, reinforcing its presence in the global diabetes treatment market. Biocon Pharma Limited, a subsidiary of Biocon Limited, has received approval from the U.S. Food and Drug Administration for Dapagliflozin Tablets in 5 mg and 10 mg strengths. The approval enables the company to market the drug for adults with type 2 diabetes mellitus, expanding its footprint in one of the world's largest pharmaceutical markets. T ...Read More >
New Delhi, Apr 8 (PTI) Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of dapagliflozin tablets indicated to control blood sugar in adults with type 2 diabetes mellitus. The approval by the US Food and Drug Administration (USFDA) is for dapagliflozin tablets of strengths 5 mg and 10 mg, Zydus Lifesciences said in a regulatory filing. Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycaemic co ...Read More >
New Delhi, Apr 7 (PTI) Aurobindo Pharma on Tuesday said it has received final approval from the US health regulator for its generic version of dapagliflozin tablets used to control blood sugar levels in people with type 2 diabetes. The final approval granted by the US Food & Drug Administration (USFDA) to manufacture and market dapagliflozin tablets is for strengths 5 mg and 10 mg, Aurobindo Pharma said in a regulatory filing. These are bioequivalent and therapeutically equivalent to the refer ...Read More >
Bangalore : Emcure Pharmaceuticals Ltd., (BSE: 544210, NSE: EMCURE) has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses). The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple admini ...Read More >
New Delhi, Apr 2 (PTI) Emcure Pharmaceuticals on Thursday announced a reduction in the price of its weight management drug, Poviztra, a semaglutide injection, by up to 55 per cent to expand patient access. The starting dose of Poviztra (0.25 mg) will now be available at Rs 3,999 per month (inclusive of taxes), a reduction of 55 per cent from the previous price of Rs 8,790, with the price reduction effective from April 3, 2026. Across all doses, the price of Poviztra has been reduced by an aver ...Read More >
NEW DELHI: With prices of GLP-1 drugs crashing and their generic versions flooding the market, govt has cracked down on their misuse, inspecting 49 businesses and issuing notices while also flagging risks of unsupervised consumption in a detailed advisory.To ensure ethical pharmaceutical practices, Drug Controller General of India has intensified surveillance of unauthorised sale and promotion of the drugs. In India, GLP-1 medicines can be prescribed only by endocrinologists, internal medicine s ...Read More >
Data reveals that hypertension and diabetes rates among Army JCOs and other ranks are significantly lower than national averages, prompting further investigation into preventative measures and lifestyle factors. IMAGE: Kindly note that this image has been posted for representational purposes only. Photograph: Indian Army/ANI Photo Key Points The prevalence of hypertension and diabetes in the Indian Army's junior ranks is nearly half that of the general population, as indicated by the National F ...Read More >
* Abdominal obesity poses greater health risks than overall obesity in the Indian context * Central obesity increases risk of diabetes, hypertension, cardiovascular diseases, and fatty liver * Indians tend to accumulate abdominal fat despite appearing lean, raising cardiometabolic risk Did our AI summary help? Let us know. Switch To Beeps Mode New Delhi: Abdominal or central obesity poses a greater health risk than overall obesity, especially in the Indian context where even lean-looking ...Read More >
NEW DELHI, Apr 1: The GLP-1 based weight loss drugs are prescription medications used to treat type 2 diabetes and obesity but carry serious side effects and must only be taken under the supervision of a qualified medical specialist, the government said on Wednesday. Highlighting that multiple variants of GLP-1 drugs have been recently introduced in the Indian market, and concerns have emerged regarding their on-demand availability through retail pharmacies, online platforms, wholesalers, and we ...Read More >
New Delhi [India], April 1 (ANI): The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release. Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar. If left untreated, it can lead to complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation. Also ...Read More >
New Delhi [India], April 1 (ANI): The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release. Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar. If left untreated, it can lead to complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation. Insu ...Read More >
New Delhi, Mar 31 (PTI) Novo Nordisk India on Tuesday announced price reductions for Ozempic and Wegovy in India, days after the launch of generic versions of semaglutide injections for patients living with type 2 diabetes and obesity. Indian pharma majors recently announced the launch of their generic versions following the molecule behind products like Ozempic and Wegovy, going off patent in India. Effective April 1, 2026, the price of the starting dose of Ozempic will be reduced by 36 per c ...Read More >
A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40-50% post patent expiry. Three early movers are taking sharply different routes -- low-cost, premium, and partnerships in a high-stakes land grab. The Indian market for Glucagon-Like Peptide-1 (GLP-1) therapies is currently at an inflection point and is poised for strong expansion. The current market size for anti-obesity and diabetes GLP-1 drugs in India, as of 2025, is estimated to be between ₹1,000-1,200 cr ...Read More >
New Delhi, Mar 30 (PTI) Just a few minutes of vigorous activity each day may lower one's risk of eight major conditions, including arthritis, heart, liver and kidney disease and dementia, according to a study. While short bursts of intense, out-of-breath activity, such as running for the bus, were liked to lower disease and death risk overall, they were especially protective against inflammatory diseases, including arthritis, serious cardiovascular disease (heart attack and stroke) and dementia ...Read More >
BHUBANESWAR: India's health in 2047 will be the key to a Viksit Bharat, said Union minister of state for Science and Technology (independent charge) Dr Jitendra Singh on Thursday. Addressing the national conclave on longitudinal cohort studies (Cohort Connect 2025) at IMMT, he emphasised that India must generate strong, long-term and country-specific health evidence to guide preventive and clinical decision-making. "Indian treatment for Indian patients, Indian prevention strategy for Indian sub ...Read More >
New Delhi, Nov 6 (PTI) Drug firm Bayer on Thursday said it has received approval for its innovative therapy Kerendia for the treatment of heart failure from the Indian regulatory authorities. The product (finerenone) is already approved for chronic kidney disease (CKD) associated with type 2 diabetes (T2D). "With the expansion of finerenone's indication, we are addressing types of heart failure that account for nearly half of all heart failure cases but have had limited proven treatment option ...Read More >
Mumbai (Maharashtra) [India], November 3: Echosens, the leader in non-invasive liver diagnostics, today announced the opening of its new regional headquarters* in Mumbai, India. The new office in the Bandra Kurla Complex (BKC) will serve as the company's hub for operations across South Asia, expanding access to FibroScan® in India, Bangladesh, Bhutan, The Maldives, Nepal, and Sri Lanka. Also Read | 'Pakistan's Been Testing': US President Donald Trump Says Pakistan 'Testing' Nuclear Weapons, Def ...Read More >
Mumbai: Less than a month after Ozempic maker Novo Nordisk announced it is cutting its global workforce as part of a restructuring plan, the layoffs have hit Indian employees in Bengaluru. Junior- to mid-level employees across functions such as sales and marketing, as well as those in the company's global business services (GBS) hub, which works with its global teams, have been impacted, according to at least three people aware of the development. "At least 100-150 will be retrenched from the ...Read More >
Lucknow: Senior Samajwadi Party leader and former minister Gayatri Prajapati was attacked by a fellow inmate inside Lucknow Jail on Tuesday. The scuffle took place within the jail premises, after which prison authorities launched an internal inquiry. According to a statement issued by Dr Ramdhani, DIG Prisons, Lucknow Range, the incident occurred after Prajapati allegedly used abusive language towards another inmate, Vishwas Rajput. In response, Vishwas attacked Prajapati using a sharp object i ...Read More >
Hyderabad: Overdependence on white rice, refined grains and added sugars is fuelling a surge in diabetes and obesity among Indians, according to an ICMR-INDIAB survey. Telangana reflects the same dietary risks as the rest of the country. The study, published in Nature Medicine, found that more than 62 per cent of daily calories in Indian diets come from low-quality carbohydrates, while protein intake remains low and saturated fat consumption exceeds recommended levels in most states. In Telanga ...Read More >
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug has made headlines worldwide not just for diabetes management but also for its weight loss effects. As India faces rising rates of diabetes, Ozempic's arrival is more than just a medical update, it could influence lifestyle choices for millions.Here's all we need to know about what this new ...Read More >
New Delhi, Oct 1 (PTI) A study that analysed India's dietary consumption in relation to risk of metabolic disorders has estimated that 62 per cent of the country's total daily energy intake comes from low-quality carbohydrates, including white rice and processed whole grains. About a fourth of the world's diabetics are estimated to be living in India, significantly higher than other countries. Researchers from the Madras Diabetes Research Foundation and Indian Council of Medical Research (ICMR ...Read More >
New Delhi, Sep 30 (PTI) India's drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide injection) manufactured by Danish pharma company Novo Nordisk for use in adults with type-2 diabetes. According to sources, Ozempic, the once-a-week injection, will be available only on a doctor's prescription. "Semaglutide Injection (Ozempic@) is indicated for the treatment of adults with Insufficiently Controlled Type 2 Diabetes Mellitus as an adjunct to Diet a ...Read More >
New Delhi [India], September 30 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has approved Danish drugmaker Novo Nordisk's once-a-week injection for patients suffering from Type 2 diabetes. Also Read | Durga Puja 2025: PM Narendra Modi Participates in Durga Puja Celebrations in Delhi's CR Park on Occasion of Maha Ashtami, Prays for Everyone's Happiness and Wellbeing (See Pics). In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals wit ...Read More >
Early management of type 2 diabetes is crucial in India, where the disease poses a significant health and financial burden. Starting treatment promptly and adopting lifestyle changes can reduce long-term complications like heart disease and kidney failure. Proactive conversations with healthcare providers and adherence to treatment plans are essential for better health outcomes and reduced healthcare costs. Type 2 diabetes is not just a chronic health condition -- it's a long-term financial com ...Read More >
MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker h ...Read More >
Varanasi: The vital parameters of renowned classical vocalist Padma Vibhushan Pandit Chhannulal Mishra, who was shifted to the ICU of SSL Hospital of BHU on Saturday, showed signs of stabilization and improvement on Monday.According to a medical bulletin issued by the hospital on Monday, Mishra is currently on non-invasive ventilator support and is receiving appropriate antibiotic therapy, insulin, and other supportive treatment measures. The 89-year-old maestro was admitted to the ICU on Sept 1 ...Read More >
BusinessWire India Mumbai (Maharashtra) [India], August 26: Abbott, the global healthcare company, today announced the launch of the FreeStyle Libre 2 Plus sensor, Abbott's latest addition to the FreeStyle Libre sensor portfolio. This innovative device offers automatic glucose readings every minute straight to your phone, empowering people with diabetes to manage their condition with confidence, precision, and ease. People living with diabetes can see their glucose readings, without having to s ...Read More >
MANN, India, Aug 26 2025 (IPS) - Generally thought to be diseases of the wealthier classes, non-communicable diseases (NCDs) like hypertension and diabetes are on the rise among India's underprivileged working classes in semi-urban and rural sprawls. Take the case of Mohan Ahire. A middle-aged gardener in Pune, Mohan never realized that the heaviness in his head was a symptom of hypertension. Last summer, a mid-morning visit to the market saw him fall unconscious on return. Upon regaining consc ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.